GLYCOLIPID AND INFLAMMATORY STATUS ANALYSIS IN METFORMIN-TREATED TYPE 2 DIABETICS
Taurunum Medical Journal · 31.05.2026 · 40 (1)
DOI: 10.63696/tmj202601003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Taurunum Medical Journal, online erschienen am 31.05.2026. Verfasst von Nataša Đorđević und 7 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
<p><strong>Introduction:</strong> Type 2 diabetes mellitus (T2DM) is linked to increased vascular morbidity and mortality. Well-controlled diabetes is indicated by effective glycemic and HbA1c regulation and low-grade inflammation management. This study evaluates glycolipid control and inflammatory status in T2DM patients on metformin.</p> <p><strong>Methods</strong><strong>: </strong>A pilot study involved 11 participants divided into two groups: a T2DM group on metformin therapy and a control, non-diabetic group. Demographic, clinical, anthropometric, glycolipid (glycemia, HbA1c, TC, LDL-C, HDL-C, TG), and inflammatory parameters (CRP, FFA, PL, UA, FLI) were evaluated.</p> <p><strong>Results</strong><strong>:</strong> Significant intergroup differences were found in glycemia, HbA1c, TC, LDL-C, UA, FLI, and WC. Glycemia influenced PL (p<0.05), UA (p<0.01), and FLI (p<0.01), while HbA1c affected UA (p<0.05) and FLI (p<0.01). LDL-C and HDL-C impacted UA (p<0.05, p<0.01). Age affected FLI (p<0.05), gender influenced PL (p<0.01), and BW, BH, WC, and BMI significantly impacted UA and FLI (p<0.01).</p> <p><strong>Conclusion</strong><strong>:</strong> T2DM patients showed signs of low-grade systemic inflammation, emphasizing the need for comprehensive diabetes management and early cardiovascular risk detection. Intensified interventions are necessary for patients with inadequate glycemic control on metformin.</p>
Zitieren
APA
Đorđević, N., Zafirović, S., Radovanović, J., Stanimirović, J., Ninković, N., Gluvić, Z., Klisić, A., & Isenović, E. R. (2026). GLYCOLIPID AND INFLAMMATORY STATUS ANALYSIS IN METFORMIN-TREATED TYPE 2 DIABETICS. Taurunum Medical Journal, 40(1). https://doi.org/10.63696/tmj202601003
Vancouver
Đorđević N, Zafirović S, Radovanović J, Stanimirović J, Ninković N, Gluvić Z, et al. GLYCOLIPID AND INFLAMMATORY STATUS ANALYSIS IN METFORMIN-TREATED TYPE 2 DIABETICS. Taurunum Medical Journal. 2026;40(1). doi:10.63696/tmj202601003
BibTeX
@article{orevi2026,
author = {Đorđević, Nataša and Zafirović, Sonja and Radovanović, Jelena and Stanimirović, Julijana and Ninković, Nikola and Gluvić, Zoran and Klisić, Aleksandra and Isenović, Esma R.},
title = {GLYCOLIPID AND INFLAMMATORY STATUS ANALYSIS IN METFORMIN-TREATED TYPE 2 DIABETICS},
journal = {Taurunum Medical Journal},
year = {2026},
volume = {40},
number = {1},
doi = {10.63696/tmj202601003}
}
EUVIMED